JP2024528557A5 - - Google Patents

Info

Publication number
JP2024528557A5
JP2024528557A5 JP2023581052A JP2023581052A JP2024528557A5 JP 2024528557 A5 JP2024528557 A5 JP 2024528557A5 JP 2023581052 A JP2023581052 A JP 2023581052A JP 2023581052 A JP2023581052 A JP 2023581052A JP 2024528557 A5 JP2024528557 A5 JP 2024528557A5
Authority
JP
Japan
Prior art keywords
cyclo
compound
bicyclo
ien
ch2ch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023581052A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528557A (ja
Filing date
Publication date
Priority claimed from PCT/EP2021/086674 external-priority patent/WO2023110138A1/en
Application filed filed Critical
Priority claimed from PCT/EP2022/068212 external-priority patent/WO2023275333A1/en
Publication of JP2024528557A publication Critical patent/JP2024528557A/ja
Publication of JP2024528557A5 publication Critical patent/JP2024528557A5/ja
Pending legal-status Critical Current

Links

JP2023581052A 2021-06-30 2022-06-30 トランスグルタミナーゼ阻害剤 Pending JP2024528557A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
EP21182956.9 2021-06-30
EP21182956 2021-06-30
EP21183316 2021-07-01
EP21183316.5 2021-07-01
US202163217783P 2021-07-02 2021-07-02
US63/217,783 2021-07-02
EPPCT/EP2021/086674 2021-12-17
PCT/EP2021/086674 WO2023110138A1 (en) 2021-12-17 2021-12-17 Inhibitors of transglutaminases
EPPCT/EP2022/065437 2022-06-07
EP2022065437 2022-06-07
PCT/EP2022/068212 WO2023275333A1 (en) 2021-06-30 2022-06-30 Inhibitors of transglutaminases

Publications (2)

Publication Number Publication Date
JP2024528557A JP2024528557A (ja) 2024-07-30
JP2024528557A5 true JP2024528557A5 (cg-RX-API-DMAC7.html) 2025-07-02

Family

ID=99799108

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023581052A Pending JP2024528557A (ja) 2021-06-30 2022-06-30 トランスグルタミナーゼ阻害剤

Country Status (21)

Country Link
US (1) US20240317708A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192812B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024528557A (cg-RX-API-DMAC7.html)
CN (1) CN117561240B (cg-RX-API-DMAC7.html)
AU (1) AU2022301517A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023003951A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024000832A2 (cg-RX-API-DMAC7.html)
DK (1) DK4192812T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP24007534A (cg-RX-API-DMAC7.html)
ES (1) ES2994247T3 (cg-RX-API-DMAC7.html)
FI (1) FI4192812T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241589T1 (cg-RX-API-DMAC7.html)
HU (1) HUE069300T2 (cg-RX-API-DMAC7.html)
IL (1) IL309077A (cg-RX-API-DMAC7.html)
LT (1) LT4192812T (cg-RX-API-DMAC7.html)
MX (1) MX2023015096A (cg-RX-API-DMAC7.html)
PE (1) PE20240892A1 (cg-RX-API-DMAC7.html)
PL (1) PL4192812T3 (cg-RX-API-DMAC7.html)
RS (1) RS66209B1 (cg-RX-API-DMAC7.html)
SI (1) SI4192812T1 (cg-RX-API-DMAC7.html)
WO (2) WO2023275333A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7805983B2 (ja) 2022-03-22 2026-01-26 アッヴィ・インコーポレイテッド ブルトン型チロシンキナーゼを分解するためのピリミジン
EP4637764A1 (en) 2023-12-22 2025-10-29 Zedira GmbH Oxo-pyridine derivatives as inhibitors of transglutaminases for use in the treatment of pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054687A1 (de) * 2000-11-03 2002-05-16 N Zyme Biotec Gmbh Inhibitoren von Transglutaminasen
EP1395257A1 (en) * 2001-06-12 2004-03-10 Elan Pharmaceuticals, Inc. Macrocycles useful in the treatment of alzheimer's disease
EP2687511A1 (de) * 2012-07-17 2014-01-22 Zedira GmbH Pyridinonderivate als Gewebetransglutaminaseinhibitoren
GB201218084D0 (en) * 2012-10-09 2012-11-21 Univ Aston Novel compounds and methods for use in medicine
EP3342779A1 (en) * 2016-12-27 2018-07-04 Zedira GmbH Inhibitors of transglutaminases
TWI825144B (zh) * 2018-08-10 2023-12-11 美商思達利醫藥公司 第二型轉麩醯胺酸酶(tg2)抑制劑
IL309476A (en) * 2021-06-30 2024-02-01 Zedira Gmbh Transglutaminase inhibitors
PL4192813T3 (pl) * 2021-06-30 2024-12-23 Zedira Gmbh Inhibitory transglutaminaz

Similar Documents

Publication Publication Date Title
JP2024524458A5 (cg-RX-API-DMAC7.html)
JP2010540508A5 (cg-RX-API-DMAC7.html)
JP2023543254A5 (cg-RX-API-DMAC7.html)
JP2021528451A5 (cg-RX-API-DMAC7.html)
JPS6366153A (ja) バルプロ酸または(e)―2―バルプロエン酸誘導体、それらの製造法ならびにそれらを含有する抗てんかん剤または抗けいれん剤
JPH02134316A (ja) 活性物質としてナイトレートエステルを含有し弛緩活性を有する医薬組成物
JPS635024B2 (cg-RX-API-DMAC7.html)
JPH0358332B2 (cg-RX-API-DMAC7.html)
JP2016069321A (ja) 環構造を有するジカルボン酸モノエステルの製造方法、ジカルボン酸モノエステルアミン塩、ジカルボン酸モノエステルを用いた液晶化合物の製造方法
JPWO2025183088A5 (cg-RX-API-DMAC7.html)
JP2024528557A (ja) トランスグルタミナーゼ阻害剤
JP2018016577A (ja) エステル化合物の製造方法
JP5556078B2 (ja) キラル化合物の製造方法および製造中間体
BE1006429A3 (fr) DERIVES DE LA N-(PHENYLETHYL-bêta-OL) AMINE, UN PROCEDE POUR LEUR PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.
JPH07267947A (ja) 抗ヒスタミン化合物とその製造プロセスおよび抗ヒスタミン化合物含有の薬剤
JPH0582385B2 (cg-RX-API-DMAC7.html)
JP4599499B2 (ja) 含フッ素アルキルジエステル化合物、含フッ素アルキルエステルアミド化合物及びそれらを含有するゲル化剤
JP5350901B2 (ja) テトラフルオロエチレン骨格を有する化合物の製造方法
JPH05140064A (ja) アズレン誘導体、トロンボキサンa2及びプロスタグランジンエンドペルオキシド受容体拮抗剤及びその製法
JP2024074704A (ja) エステル化合物の製造方法、含フッ素エステル化合物の製造方法、及び含フッ素エステル化合物
JP2913157B2 (ja) 新規な炭素環系スルホンアミド誘導体
JPH0427977B2 (cg-RX-API-DMAC7.html)
JP2024128248A (ja) フッ素系界面活性剤
JPWO1992017462A1 (ja) N−シアノイミノ複素環式化合物
RU2021122314A (ru) Антигипертензивное полиольное соединение и его производное